AVROBIO, Inc. Expands Rare Disease Pipeline with Gene Therapy to Treat Pompe DiseaseBusiness Wire (press release)CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVROBIO, Inc., a clinical-stage biotechnology company developing transformative, life-changing gene ther… Continue reading
Cystic Fibrosis News TodayCF Foundation Affiliate Awards $3M to Advance Gene Therapy Candidate to TrialsCystic Fibrosis News Today4D Molecular Therapeutics (4DMT) announced it has secured funding to complete studies necessary for its gene therapy candi… Continue reading
MesotheliomaHelp.org (blog) |
New Immune Cell May Predict Which Mesothelioma Patients Will Benefit From Immunotherapy
MesotheliomaHelp.org (blog) Now, one team of researchers is looking more closely at immune cells to predict which lung cancer patients will benefit most from immunotherapy, and the findings look hopeful for mesothelioma patients as well. In a study from Cancer Research UK, … Immunotherapy Drugs Market Size and Forecast, 2016 – 2024satPRnews (press release) Scientists here testing new treatment for ovarian cancerChina Post |
Drug Discovery & Development |
CRISPR Developer Awarded Lemelson-MIT Prize
Drug Discovery & Development Dr. Feng Zhang, a pioneer of the revolutionary CRISPR gene editing technology, TAL effectors, and optogenics, has just been announced as the recipient of the 2017 $500,000 Lemelson-MIT Prize, the largest cash prize for invention in the United States. |
MIT Technology Review |
Even at $500K, Gene Therapy Could Be a Bargain for Some Diseases
MIT Technology Review The U.S. Food and Drug Administration recently approved what it called the “first gene therapy” in the country. The therapy, called Kymriah and made by Novartis, uses a patient’s own cells—which are genetically modified outside the body—to treat a … Novel Gene Therapy and Antisense Drugs to Offer Effective Cancer CureTMR Research Blog (press release) (blog) |